These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146 [TBL] [Abstract][Full Text] [Related]
4. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553 [TBL] [Abstract][Full Text] [Related]
5. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114 [TBL] [Abstract][Full Text] [Related]
6. GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future. Atkinson P; Koch J; Susic D; Ledger WL Womens Health (Lond); 2014 May; 10(3):267-76. PubMed ID: 24956293 [TBL] [Abstract][Full Text] [Related]
7. Reply: GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients. Ata B; Seyhan A; Polat M; Son WY; Yarali H; Dahan M Hum Reprod; 2013 Sep; 28(9):2594-5. PubMed ID: 23842563 [No Abstract] [Full Text] [Related]
8. GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients. Humaidan P; Thomsen LH; Alsbjerg B Hum Reprod; 2013 Sep; 28(9):2593-4. PubMed ID: 23842562 [No Abstract] [Full Text] [Related]
9. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis. Xiao J; Chen S; Zhang C; Chang S Gynecol Endocrinol; 2013 Mar; 29(3):187-91. PubMed ID: 23194095 [TBL] [Abstract][Full Text] [Related]
10. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639 [TBL] [Abstract][Full Text] [Related]
11. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger. Fatemi HM; Garcia-Velasco J Fertil Steril; 2015 Apr; 103(4):870-3. PubMed ID: 25724740 [TBL] [Abstract][Full Text] [Related]
12. Withdrawal of GnRH agonist decreases oestradiol and VEGF concentrations in high responders. Ding LJ; Wang B; Shen XY; Yan GJ; Zhang NY; Hu YL; Sun HX Reprod Biomed Online; 2013 Aug; 27(2):131-9. PubMed ID: 23764202 [TBL] [Abstract][Full Text] [Related]
13. 'GnRH agonist trigger: looking for the coin under the lamp post?'. Kol S Hum Reprod; 2006 May; 21(5):1328; author reply 1328-9. PubMed ID: 16611976 [No Abstract] [Full Text] [Related]
14. Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases. Gurbuz AS; Deveer R; Ozcimen N; Ozcimen EE; Lawrenz B; Banker M; Garcia-Velasco JA; Fatemi HM Gynecol Endocrinol; 2016; 32(1):18-20. PubMed ID: 26487486 [TBL] [Abstract][Full Text] [Related]
15. [Application of gonadotropin-releasing hormone agonist for triggering ovulation in high risk gonadotropin stimulating cycles of infertile polycystic ovary syndrome patients]. Dong H; Chen S; Xing F Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):94-6. PubMed ID: 11263206 [TBL] [Abstract][Full Text] [Related]
17. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders. Bar-Hava I; Mizrachi Y; Karfunkel-Doron D; Omer Y; Sheena L; Carmon N; Ben-David G Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332 [TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone agonist (GnRHa) trigger - State of the art. Dosouto C; Haahr T; Humaidan P Reprod Biol; 2017 Mar; 17(1):1-8. PubMed ID: 28215488 [TBL] [Abstract][Full Text] [Related]
19. Treatment with gonadotropin-releasing hormone (GnRH) antagonists in women suppressed with GnRH agonist may avoid cycle cancellation in patients at risk for ovarian hyperstimulation syndrome. Gustofson RL; Larsen FW; Bush MR; Segars JH Fertil Steril; 2006 Jan; 85(1):251-4. PubMed ID: 16412770 [TBL] [Abstract][Full Text] [Related]